Cotarelo, Cristina L.
Zschöck-Manus, Annemarie
Schmidt, Marcus
Schad, Arno
Brochhausen, Christoph
Kirkpatrick, Charles James
Thaler, Sonja
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 19 April 2020
Accepted: 15 November 2020
First Online: 29 November 2020
Compliance with ethical standards
:
: M Schmidt received honoraria for speaker or consultancy role from AMGEN, AstraZeneca, Eisai, Lilly, Myelo Therapeutics, Novartis, Pantarhei Bioscience, Pfizer, and Roche. He received research funding from AstraZeneca, BioNTech, Eisai, Genentech, Myelo Therapeutics, Novartis, Pantarhei Bioscience, Pierre-Fabre, and Roche. He received travel reimbursement from Pfizer and Roche.
: All participants provided written informed consent that was documented in the patient file. The study design and the consent procedure were approved by the ethical review board of the medical association of Rhineland-Palatinate. All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki. Ethical standards: The experiments comply with the current laws of Germany.